Active Ingredients (Per Tablet)
Acetaminophen 325 mg
Chlorpheniramine Maleate 4 mg
Phenylephrine HCl 10 mg
The following Structured Product Label (SPL) was submitted to the FDA by U.s. Pharmaceutical Corporation for the product Norel Ad (NDC 52747-475). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients (per tablet), purpose, uses, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Acetaminophen 325 mg
Chlorpheniramine Maleate 4 mg
Phenylephrine HCl 10 mg
Pain reliever
Antihistamine
Nasal decongestant
Temporarily relieves these symptoms due to the common cold or flu
Liver warning: This product contains acetaminophen. Severe liver damage may occur if
Sore throat warning: If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea or vomiting, speak with a healthcare provider.
Taking more than the recommended dose can cause serious health problems. In case of overdose, get medical help or contact Poison Control Center right away. Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
store at 20°-25°C (68°-77°F)
Overdose Warning: Keep this and all medication out of the reach of children. In case of accidental overdose, seek medical help or contact a Poison Control Center immediately.
Colloidal Silicon Dioxide, Crospovidone Polyplasdone, Magnesium Stearate (vegetable base), Microcrystalline Cellulose, Povidone K-30, Pregelatinized Starch, Stearic Acid, D&C Yellow #10, FD&C Yellow #6.
Please visit www.uspco.com or contact us at US Pharmaceutical Corporation, P.O. Box 360465, Decatur, GA 30036
* Please review the disclaimer below.